Qunyou Tan
Overview
Explore the profile of Qunyou Tan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Y, Gu J, Yan Z, Hu X, He D, Zhang Y, et al.
Nanoscale
. 2024 Nov;
16(47):22048-22049.
PMID: 39574406
Correction for 'Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component for effective asparaginase supramolecule delivery' by Yongjia Huang , , 2020, , 12083-12097, https://doi.org/10.1039/D0NR02588G.
2.
Yuan Y, Xiang X, Jiang X, Liu Y, Zhang M, Lu L, et al.
Antioxidants (Basel)
. 2024 Sep;
13(9).
PMID: 39334763
The seeds of ginkgo biloba L (GB) have been widely used worldwide. This study investigated the bioefficacies of whole GB seed powder (WGP) retaining the full nutrients of ginkgo against...
3.
Liu B, Ye X, Fan W, Zhi X, Ma H, Wang J, et al.
J Cancer Res Ther
. 2024 Aug;
20(4):1109-1123.
PMID: 39206972
This expert consensus reviews current literature and provides clinical practice guidelines for the diagnosis and treatment of multiple ground glass nodule-like lung cancer. The main contents of this review include...
4.
Xu J, Wu M, Yang J, Zhao D, He D, Liu Y, et al.
Nat Nanotechnol
. 2024 Jul;
19(10):1544-1557.
PMID: 39020102
Gouty arthritis is a chronic and progressive disease characterized by high urate levels in the joints and by an inflammatory immune microenvironment. Clinical data indicate that urate reduction therapy or...
5.
Dai F, Wu X, Wang X, Li K, Wang Y, Shen C, et al.
Front Oncol
. 2022 Nov;
12:1022123.
PMID: 36353552
Background: Programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors displayed considerable advantages in neoadjuvant therapy of non-small cell lung cancer (NSCLC), but the specific application of neoadjuvant immunotherapy has not been...
6.
Sun T, Zhang J, Fan X, Long T, Tao S, Kang P, et al.
J Oncol
. 2021 Dec;
2021:9958483.
PMID: 34899911
Reduced sensitivity to chemotherapeutic drugs is almost inevitable in lung adenocarcinoma patients. Thus, understanding the relevant mechanisms is urgent. Positive cofactor 4 (PC4) was at first revealed to be a...
7.
Yang J, Fang C, Liu H, Wu M, Tao S, Tan Q, et al.
Nanoscale
. 2021 Sep;
13(35):15085-15099.
PMID: 34533154
The discovery of effective anticancer drug delivery systems and elucidation of the mechanism are enormous challenges. Using two drug administration-approved biomaterials, we constructed a natural medicine (NM)-loaded ternary supramolecular nanocomplex...
8.
Huang Y, Wang T, Tan Q, He D, Wu M, Fan J, et al.
Int J Nanomedicine
. 2021 Jun;
16:4117-4146.
PMID: 34163163
Dysfunction in the mitochondria (Mc) contributes to tumor progression. It is a major challenge to deliver therapeutic agents specifically to the Mc for precise treatment. Smart drug delivery systems are...
9.
Chen D, Kang P, Tao S, Li Q, Wang R, Tan Q
Lung Cancer
. 2021 Jan;
153:99-107.
PMID: 33482409
Background: This study aimed to evaluate the cost-effectiveness of robotic-assisted thoracoscopic surgery (RATS) over open thoracotomy (OT) and video-assisted thoracoscopic surgery (VATS) for operable non-small cell lung cancer (NSCLC) from...
10.
Chen D, Kang P, Tao S, Wu L, Li Q, Tan Q
Updates Surg
. 2021 Jan;
73(4):1549-1558.
PMID: 33398772
Background: This study aimed to investigate risk factors of conversion to thoracotomy for patients with non-small cell lung cancer (NSCLC) underwent robotic- (RATS) or video-assisted thoracoscopic surgery (VATS). Methods: A...